BMY
Bristol-Myers Squibb Company
- Stock buybacks, 2025
- $0
Stock buybacks
Stock buybacks by fiscal year
| Period | Buybacks | YoY |
|---|---|---|
| 2025 | $0 | — |
| 2024 | $0 | −100.0% |
| 2023 | $5.2B | −35.6% |
| 2022 | $8.0B | +27.3% |
| 2021 | $6.3B | +306.7% |
| 2020 | $1.5B | −78.8% |
| 2019 | $7.3B | +2,181.3% |
| 2018 | $320M | −87.0% |
| 2017 | $2.5B | +968.8% |
| 2016 | $231M | — |
| 2013 | $433M | −82.0% |
| 2012 | $2.4B | +96.8% |
| 2011 | $1.2B | +112.0% |
| 2010 | $576M | — |